DSM issues long-term €500 million bond

Royal DSM, the global Life Science and Materials Sciences company, has successfully issued a €500 million 1.375% bond due 2022.

The proceeds will be used for general purposes.

The terms are laid down in the €4 billion Debt Issuance Program of Royal DSM, the final terms and the supplements thereto, which are available on the Investor Relations website.

The re-offer price was 99.841%. Based on this price the yield is 1.399%. The bond will be listed on Euronext Amsterdam shortly.

This release does not constitute an offer or an invitation to subscribe for or purchase any securities. The notes are being offered only by means of a prospectus.

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.

Or find us on:        

For more information: